Summary & Overview
HCPCS S9563: Home Injectable Immunotherapy, Per‑Diem
HCPCS Level II code S9563 designates a per‑diem bundled service for home injectable immunotherapy that covers administrative services, professional pharmacy services, care coordination, and necessary supplies and equipment while excluding drug product and nursing visit charges. This code matters nationally as home‑based immunotherapy expands care options for patients requiring injectable biologic or allergen immunotherapies and as payers and providers negotiate appropriate coverage and billing workflows.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical and billing context for home immunotherapy services, guidance on payer coverage considerations, and the types of benchmarks and policy updates typically relevant for per‑diem bundled HCPCS services. The publication also addresses operational elements such as service setting (home), what the per‑diem bundle includes and excludes, and implications for coding and claims submission.
The document is intended for billing managers, pharmacy services, home health program leads, and payer policy analysts who need a national‑level summary of S9563, expected use cases, and the categories of information to consult when implementing or reviewing coverage for home injectable immunotherapy.
Billing Code Overview
HCPCS Level II code S9563 describes home injectable therapy, immunotherapy, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem. This code represents a bundled per‑day payment for the non-drug and non-nursing components of home-based immunotherapy administration.
-
Service type: Home-based immunotherapy administration with administrative and pharmacy professional services, care coordination, and supplies
-
Typical site of service: Patient residence (home)
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient receiving S9563 is an adult with a chronic allergic or immunologic condition requiring regular home-based injectable immunotherapy and care coordination. Example: a 45-year-old patient with severe allergic rhinitis and venom hypersensitivity who receives subcutaneous allergen immunotherapy at home because of mobility limitations and home health plan enrollment. The home health agency provides per-diem administrative and professional pharmacy services, coordination of nursing visits, scheduling, and supply management while the drug product is billed separately and nursing visits or injections are billed using appropriate service codes.
Workflow:
-
Referral and order placed by the treating allergist or primary care provider.
-
Clinical review and prior authorization by the payer, with documentation of diagnosis, immunotherapy plan, and safety monitoring.
-
Pharmacy prepares patient-specific injectable immunotherapy; drug charges billed separately.
-
Home health agency bills
S9563per diem for administrative services, professional pharmacy services, care coordination, and supplies; nursing visits and injection administration billed separately under nursing visit codes. -
Nursing staff perform home visits for injection administration, observe for immediate reactions, document vitals and adverse events, and communicate outcomes to the ordering clinician.
-
Ongoing coordination includes monitoring for adverse events, vaccine or antitoxin handling if applicable, resupply of allergens, and periodic clinician review of dose escalation or maintenance.